MetaCap

Immuneering (IMRX) News

NASDAQ: IMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.38-0.07 (-2.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

IMRX news summary

We found 13 recent headlines mentioning Immuneering (IMRX): 3 in the past week and 13 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, IMRX is down 2.03% at $3.38. The most recent story, "Immuneering Releases Data Validating Atebimetinib As MAPK Backbone In Pancreatic & Thyroid Cancer", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Immuneering headlines

Stocks mentioned alongside IMRX

Compare IMRX